Genolution

Genolution Interest Coverage

The Interest Coverage Ratio of Genolution (225220.KQ) as of Oct 22, 2026 is -3.66. In the previous year, Interest Coverage Ratio was -2.06 — a change of 77.82% (lower).

Interest Coverage

-3.66

YoY

77.82%

Last updated:

Interest Coverage Ratio of Genolution is 2024 -3.66 . Interest Coverage Ratio of Genolution was 2023 -2.06 . It decreases by 77.82% lower compared to the previous year.

The Genolution Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
12.56 KRW
Jan 1, 2018
0.16 KRW
Jan 1, 2019
0.34 KRW
Jan 1, 2020
5.03 KRW
Jan 1, 2021
15.96 KRW
Jan 1, 2022
8.02 KRW
Jan 1, 2023
-2.06 KRW
Jan 1, 2024
-3.66 KRW
The Genolution Interest Coverage history
YEARInterest CoverageYoY
-3.66+77.82%
-2.06-125.69%
8.02-49.77%
15.96+217.42%
5.03+1,384.80%
0.34+105.88%
0.16-98.69%
12.56+173.98%
4.59—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genolution Stock analysis

What does Genolution do? Genolution Inc develops automated nucleic acid extraction devices, nucleic acid extraction reagents, and molecular diagnostic products. The company also offers ribonucleic acid interference services. Its products are distributed domestically and internationally, serving customers in the biotechnology and healthcare sectors. The firm generates revenue through the sale of these products and services to research institutions, laboratories, and healthcare providers. The company's core offerings include nucleic acid extractors, reagents, and diagnostic products, which are used in molecular biology and medical diagnostics. Genolution Inc targets biotech firms, hospitals, and research facilities as key buyers of its technology. Its domestic market presence complements its international distribution channels. Genolution Inc's business model relies on selling its automated extraction devices and reagents to customers requiring efficient nucleic acid processing solutions. The company's molecular diagnostic products cater to healthcare applications, while its ribonucleic acid interference services support advanced research needs. Revenue streams are derived from both product sales and service contracts within the biotechnology industry. Genolution is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genolution stock

Interest Coverage Ratio of Genolution is -3.66 in 2024.

Interest Coverage Ratio of Genolution changed from -2.06 to -3.66, representing a 77.82% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Genolution since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Genolution with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Genolution

All Key Metrics — Genolution